Literature DB >> 17190126

Long term oxygen therapy adherence and COPD: what we don't know.

D L Cullen1.   

Abstract

Persons utilizing long term oxygen therapy (LTOT) at home suffer from chronic obstructive pulmonary disease (COPD). Adherence to LTOT ranges from 45% to 70% and utilization of 15 hours per day is widely accepted as efficacious. Although studies have reviewed the level of patient adherence with LTOT, few have introduced or evaluated interventions. The paucity of information regarding patients following oxygen prescription is an enormous void that must be tackled to augment clinical effectiveness and cost containment for the long term. A research agenda for LTOT adherence is postulated to help connect treatment adherence variables and concepts with clinical outcomes and quality of life.

Entities:  

Mesh:

Year:  2006        PMID: 17190126     DOI: 10.1177/1479972306070506

Source DB:  PubMed          Journal:  Chron Respir Dis        ISSN: 1479-9723            Impact factor:   2.444


  8 in total

1.  Characteristics at the time of oxygen initiation associated with its adherence: Findings from the COPD Long-term Oxygen Treatment Trial.

Authors:  Marilyn L Moy; Kathleen F Harrington; Alice L Sternberg; Jerry A Krishnan; Richard K Albert; David H Au; Richard Casaburi; Gerard J Criner; Philip Diaz; Richard E Kanner; Ralph J Panos; Thomas Stibolt; James K Stoller; James Tonascia; Roger D Yusen; Ai-Yui M Tan; Anne L Fuhlbrigge
Journal:  Respir Med       Date:  2019-02-13       Impact factor: 3.415

2.  Knowledge, attitude, and practice of health professionals for oxygen therapy working in South Gondar zone hospitals, 2021: multicenter cross-sectional study.

Authors:  Basazinew Chekol Demilew; Agegnehu Mekonen; Agazhe Aemro; Nakachew Sewnet; Banchiayehu Alebachew Hailu
Journal:  BMC Health Serv Res       Date:  2022-05-04       Impact factor: 2.908

3.  Ambulatory oxygen therapy with documented self-monitoring of oxygen use improves health status among patients with chronic obstructive pulmonary disease.

Authors:  Youlim Kim; Hye Yun Park; Chin Kook Rhee; Kyung Hoon Min; Kwang Ha Yoo; Seong Yong Lim; Yee Hyung Kim; Seung Hun Jang; Ki-Suck Jung; Yong Il Hwang
Journal:  J Thorac Dis       Date:  2022-05       Impact factor: 3.005

4.  Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease.

Authors:  Rebecca E Schane; Louise C Walter; Alexis Dinno; Ken E Covinsky; Prescott G Woodruff
Journal:  J Gen Intern Med       Date:  2008-08-09       Impact factor: 5.128

5.  Long-Term Oxygen Therapy in COPD: Factors Affecting and Ways of Improving Patient Compliance.

Authors:  Stamatis Katsenos; Stavros H Constantopoulos
Journal:  Pulm Med       Date:  2011-09-15

6.  The impact of care pathways for exacerbation of Chronic Obstructive Pulmonary Disease: rationale and design of a cluster randomized controlled trial.

Authors:  Kris Vanhaecht; Walter Sermeus; Jan Peers; Cathy Lodewijckx; Svin Deneckere; Fabrizio Leigheb; Marc Decramer; Massimiliano Panella
Journal:  Trials       Date:  2010-11-19       Impact factor: 2.279

7.  Capillary PO2 does not adequately reflect arterial PO2 in hypoxemic COPD patients.

Authors:  Friederike Sophie Magnet; Daniel Sebastian Majorski; Jens Callegari; Sarah Bettina Schwarz; Claudia Schmoor; Wolfram Windisch; Jan Hendrik Storre
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-09-06

8.  Adherence to long-term oxygen therapy in patients with chronic obstructive pulmonary disease.

Authors:  Amélie Gauthier; Sarah Bernard; Emmanuelle Bernard; Serge Simard; François Maltais; Yves Lacasse
Journal:  Chron Respir Dis       Date:  2018-04-09       Impact factor: 2.444

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.